NRP1‐shRNA lentiviral interference vectors can effectively decrease NRP1 gene expression in PACA cells, thereby inhibiting cells proliferation and migration, which provides a basis for finding a valuable therapeutic target for PACA therapy. The gene discussed is NRP1; the disease is permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.